Treatment with angiotensin receptor neprilysin inhibitor for Taiwan heart failure patients: Rationale and baseline characteristics of the TAROT-HF study-Reference-Cited by-同舟云学术

Treatment with angiotensin receptor neprilysin inhibitor for Taiwan heart failure patients: Rationale and baseline characteristics of the TAROT-HF study

Published:2021-07-07 Issue:9 Volume:84 Page:833-841
ISSN:1726-4901
Container-title:Journal of the Chinese Medical Association
language:en
Short-container-title:

Author:

Lin Wen-Yu,Chung Fa-Po,Liao Chia-Te,Huang Jin-Long,Liang Huai-Wen,Lee Ying-Hsiang,Lin Po-Lin,Chiou Wei-Ru,Hsu Chien-Yi,Chang Hung-Yu

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference29 articles.

1. Epidemiology and risk profile of heart failure.;Bui;Nat Rev Cardiol,2011

2. Clinical epidemiology of heart failure.;Mosterd;Heart,2007

3. Epidemiology of heart failure in Asia.;Sakata;Circ J,2013

4. The EuroHeart Failure survey programme– a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis.;Cleland;Eur Heart J,2003

5. Heart failure as a general pandemic in Asia.;Shimokawa;Eur J Heart Fail,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Taiwan Society of Cardiology Heart Failure Registry 2020: Rationale and Design;ACTA CARDIOL SIN;2024

2. Risk stratification for worsening renal function and renal decline in heart failure patients with reduced ejection fraction after sacubitril/valsartan treatment;Journal of Cardiology;2023-12

3. Iron deficiency in Taiwanese patients with heart failure and reduced ejection fraction;Journal of the Chinese Medical Association;2023-06-14

4. Real-World Experience of Angiotensin Receptor–Neprilysin Inhibition in Reduced Ejection Fraction Heart Failure Patients With Advanced Kidney Disease;Mayo Clinic Proceedings;2023-01

5. Real-world use patterns of angiotensin receptor-neprilysin inhibitor (sacubitril/valsartan) among patients with heart failure within a large integrated health system;Journal of Managed Care & Specialty Pharmacy;2022-10